Cell Biochemistry and Biophysics

, Volume 70, Issue 3, pp 1803–1806 | Cite as

Investigation on Etiology of Hepatic Venous Obstruction Budd-Chiari Syndrome

  • Zhi-Long Tian
  • Gao-Lei Jia
  • Hai-Lin Xi
  • Su Feng
  • Xiao-Kai Wang
  • Rui Li
Original Paper
First Online:

Abstract

Budd-Chiari syndrome (BCS) is an uncommon clinical condition with a complex etiology. Pathogenesis of BCS is still poorly understood. We included hepatic veno-occlusive lesion tissues of 20 patients (patients group) with hepatic venous obstruction BCS and compared with 20 similar tissues with other etiologies (control group). Morphological changes in hepatic veno-occlusive lesion tissues and the positive expression of proliferating cell nuclear antigen (PCNA), C-myc, and P-53 were observed by the pathological examination (H&E staining) and immunohistochemistry assay. Our results showed that PCNA and C-myc positive cell densities were significantly higher in patient group than control group. P-53 positive cell density showed increasing trends in patients than control group. Moreover, we observed irregular hyperplasia in intimal tissue, fibrous connective tissue, and smooth muscle cell, accompanied by tissue degeneration (hyaloid degeneration and fibrinoid degeneration) and a large quantity of inflammatory cell infiltration. In conclusion, an overexpression of PCNA, C-myc, and a weak positive expression of P53 might launch the extremely irregular hepatic venous intimal hyperplasia, which is probably one of the etiologies of hepatic venous obstruction BCS.

Keywords

Budd-Chiari syndrome Hepatic venous occlusion Intimal proliferation 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Rajani, R., Melin, T., Bjornsson, T., et al. (2009). Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival—an 18-year experience. Liver International, 29, 253–259.PubMedCrossRefGoogle Scholar
  2. 2.
    Bozorgmanesh, A., Selvam, D. A., & Caridi, J. G. (2007). Budd-Chiari syndrome: Hepatic venous web outflow obstruction treated by percutaneous placement of hepatic vein stent. Seminars in Interventional Radiology, 24, 100–105.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Rha, S. E., Lee, M. G., Lee, Y. S., et al. (2002). Nodular regenerative hyperplasia of the liver in Budd-Chiari syndrome. CT and MR features. Abdominal Imaging, 25, 255–258.CrossRefGoogle Scholar
  4. 4.
    Nakase, H., Kawasaki, T., Itani, T., et al. (2001). Budd-Chiari syndrome and extrahepatic portal obstruction associated with congenital antithrombin III deficiency. Journal of Gastroenterology, 36, 341–345.PubMedCrossRefGoogle Scholar
  5. 5.
    Sipahi, T., Duru, F., Yarah, N., et al. (2001). Compound heterozygosity for factor V Leiden and prothrombin G20210A mutations in a child with Budd-Chiari syndrome. European Journal of Pediatrics, 160, 198.PubMedCrossRefGoogle Scholar
  6. 6.
    Liu, Y. Y., Zhang, Y., Huang, Y. G., et al. (2003). Relationship between expression of p53, nm23, PCNA and invasion and metastasis of colon carcinoma. Guangdong Medical Journal, 4, 381.Google Scholar
  7. 7.
    Bian, J. F., Zhang, B. G., & Chen, S. S. (1999). Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells. Zhonghua Yi Xue Za Zhi, 79, 10–14.PubMedGoogle Scholar
  8. 8.
    Bioulac-Sage, P., & Balabaud, C. (2001). Liver nodules resembling focal nodular hyperplasia. Journal of Hepatology, 34, 781.PubMedCrossRefGoogle Scholar
  9. 9.
    Bennett, M. R., Evan, G. I., & Newby, A. C. (1994). Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-gamma, heparin, and cyclic nucleotide analogues and induces apoptosis. Circulation Research, 74, 525–536.PubMedCrossRefGoogle Scholar
  10. 10.
    Tao, Q. G., Zhang, Z. X., & Xu, Y. J. (1999). Investigation on c-myc and p53 gene expression and proliferation, apoptosis of pulmonary vascular wall cells in chronic hypoxic rats. Chinese Journal of Applied Physiology, 15, 169.Google Scholar
  11. 11.
    Huang, X. R., Lai, R. Q., Wang, Z. C., et al. (2000). The relationship between the expression of p16, p53, Rb gene protein or proliferating nuclear antigen and clinicopathologic features of human gastric cancer. Chinese Journal of Cancer, 19, 899.Google Scholar
  12. 12.
    Riedel, F., Gotte, K., Schwalb, J., et al. (2002). Vascular endothelial growth factor expression correlates with P53 mutation and angiogenesis in squamous cell carcinoma of the head and neck. Acta Otolaryngologica, 120, 105–111.Google Scholar
  13. 13.
    Kage, M., Arakawa, M., Kojiro, M., et al. (1992). Histopathology of membranous obstruction of the inferior vena cava in the Budd-Chiars’s syndrome. Gastroenterology, 102, 2081–2090.PubMedGoogle Scholar
  14. 14.
    Aguirrebarrena, G., Pulcinelli, S., Giovannoni, A. G., & Gidekel, L. (2001). Celiac disease and Budd-Chiari syndrome: Infrequent association. Revista Espanola de Enfermedades Digestivas, 93, 611–612.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Zhi-Long Tian
    • 1
  • Gao-Lei Jia
    • 1
  • Hai-Lin Xi
    • 1
  • Su Feng
    • 1
  • Xiao-Kai Wang
    • 1
  • Rui Li
    • 2
  1. 1.Department of General Surgery, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical CollegeAffiliated Hospital of Southeast UniversityXuzhouChina
  2. 2.Department of Central Laboratory, Xuzhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical CollegeAffiliated Hospital of Southeast UniversityXuzhouChina

Personalised recommendations